On Friday, SyntheticMR announced that Ulrik Harrysson, who has been on medical leave since 4 December, has resigned from his role as CEO. Vedran Beglerbegovic, currently acting CEO and previous Chief Operating Officer, has been appointed new CEO with immediate effect. The change in leadership comes as SyntheticMR enters a new phase following the acquisition of Combinostics. Given Mr Beglerbegovic's previous experience from SyntheticMR, we expect the change to be undramatic.

SEB Research

This research has been commissioned by the company. Only for professional investors resident in EEA member states. Reports may not be distributed to the US or other jurisdictions where to do so would be unlawful. Please see the disclaimer tab for any details of investment banking services recently provided by SEB that could be considered relevant to the subject matter of this research.